Dihydroergotamine Mesylate
NDC Package 61990-0411-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dihydroergotamine Mesylate is a medication used to treat migraine headache attacks. Marketed by Apollo Pharmaceuticals Inc., this product is identified by NDC 61990-0411 and is authorized under FDA application ANDA212046.

Identification & Billing

NDC Package Code
61990-0411-2
Package Description
10 AMPULE in 1 CARTON / 1 mL in 1 AMPULE (61990-0411-0)
Product Code
61990-0411
11-Digit Billing Format
61990041102
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Dihydroergotamine Mesylate
Dosage Form
-
Usage Information
This medication is used to treat migraine headache attacks. It helps relieve headache pain and other symptoms such as sensitivity to light or sound. Prompt treatment allows you to get back to your normal routine sooner and may decrease your need for other pain medications. This medication is not used to prevent migraines from occurring. Dihydroergotamine belongs to a class of drugs known as ergot alkaloids. It may work by narrowing the blood vessels in the brain. It may also block other pain pathways in the brain.

Regulatory & Marketing

Labeler Name
Apollo Pharmaceuticals Inc.
FDA Application #
ANDA212046
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-14-2020
End Marketing Date
03-31-2024
Listing Expiration
03-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J1110
Source: PDAC
INJECTION, DIHYDROERGOTAMINE MESYLATE, PER 1 MG
HCPCS Dosage 1 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (61990-0411). Click a package code to view its specific billing and regulatory data.

61990-0411-1
5 AMPULE in 1 CARTON / 1 mL in 1 AMPULE (61990-0411-0)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61990-0411-2 identifies a specific commercial package of 10 ampule in 1 carton / 1 ml in 1 ampule (61990-0411-0) of Dihydroergotamine Mesylate, labeled by Apollo Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apollo Pharmaceuticals Inc. on April 14, 2020. The current certification is valid through March 31, 2024.

What are the primary indications for this medication?

This medication is used to treat migraine headache attacks. It helps relieve headache pain and other symptoms such as sensitivity to light or sound. Prompt treatment allows you to get back to your normal routine sooner and may decrease your need for other pain medications. This medication is not used to prevent migraines from occurring. Dihydroergotamine belongs to a class of drugs known as ergot alkaloids. It may work by narrowing the blood vessels in the brain. It may also block other pain pathways in the brain.

How is this Apollo Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61990041102. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
61990-0411-2
11-Digit CMS (5-4-2)
61990-0411-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.